Effectiveness of Individualized Homoeopathic Medicines in the Management of Chronic Venous Diseases: An Exploratory Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 35
- 试验地点
- 2
- 主要终点
- Decrease in total score of Revised VCSS will signify improvement in signs and symptoms of chronic venous disease.
研究概览
简要总结
This exploratory study aims to evaluate the effectiveness of individualized homoeopathic medicines in the management chronic venous diseases. The duration of the study is 15 months. Participants will be screened and enrolled as per the inclusion and exclusion criteria. The expected outcome is significant improvement in the signs and symptoms of chronic venous disease by measuring changes in the CEAP clinical rating, the Revised Venous Clinical Severity Score (VCSS), and the quality of life of patients using CIVIQ-20, both before and after treatment. The result will be concluded accordingly.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 79.00 Year(s)（—）
- 性别
- All
入选标准
- •Participants presented between C0 and C6 according to CEAP clinical rating.
- •Participants presenting with visible varicose veins with varicose or stasis eczema, varicose ulcers, itching, pain, heaviness, numbness, and swelling in lower limbs.
- •Age above 18 All genders.
排除标准
- •Pregnancy, lactating mother, secondary causes of chronic venous disease or varicose veins (abdominal tumors).
- •Any participants presenting with deep vein thrombosis, thrombophlebitis, severe systemic illness, immunocompromised, under the influence of substance abuse, and any psychiatric illness.
- •Participants who need surgical intervention.
- •Participants who refuse to give consent.
- •Participants who are under any other sort of treatment.
结局指标
主要结局
Decrease in total score of Revised VCSS will signify improvement in signs and symptoms of chronic venous disease.
时间窗: Revised Venous clinical severity score will be evaluated at Baseline, 4 weeks, 8 | weeks, 12 weeks till 24 weeks | Study Duration 15 months | Enrollment period (6 months) | Follow-up duration (6 months) | Data analysis and report writing (3 months) | First dose will be given after case taking and
次要结局
- Improvement in participant quality of life score as measured by validated CIVIQ-20.
研究者
Dr Laviza Arzoo
Bakson Homoeopathic Medical College And Hospital